学术会议:紧随研究趋势 洞察学术热点 进入>
产业会议:新技术,新领域,深入产业环节 进入>
举办会议及论坛超过百场 邀请海内外院士超过50名 教授PI专家授课超过1000名 总参会人数超过10万人
2018-06-29至2018-06-29 上海
导航

已确认嘉宾Confirmed Guests

Alessandra Eleuteri

DEL Manager, LGC

Alessandra Eleuteri

DEL Manager, LGC

SUMMARY

 

Result driven manager with a strong technical background and years of experience in the fields of pharmaceuticals, medical devices, and combination including areas of research, manufacturing, quality assurance and business development/sales. Accomplished in managing projects and building teams of highly qualified scientists to meet or exceed timelines, quality goals, and financial targets. A strong technical and analytical problem solver with a collaborative management style that uses team based approaches to generate different visions and perspectives to gain the best chance at solving the most difficult problems and driving projects to success

 

• Business Development • cGMP Regulations • Project Leadership

 

• Research and Development • Project management • Collaborative Management

_____________________________________________________________________________________________________________

 

PROFESSIONAL EXPERIENCE

 

LGC Biosearch Technologies May 2014 - present Technical Sales Specialist

 

Responsible for business development and account management for two key business units within LGC Genomics: custom oligonucleotides for DNA encoded library technology and oligonucleotides for therapeutic use. Accountable for building the European and North American therapeutic oligonucleotide business from the ground-up and for expanding the global market for reagents for DNA encoded library technology. Successfully exceeded all sales target by prospecting, new lead generation and qualification and increased close rate

 

• Solely responsible for the identification of new business opportunities, establishment of new partnerships and management of alliances with large pharmaceutical companies focusing on DNA encoded library technology while maintaining a consistent 30% annual accounts growth

 

• Track record in identifying novel business opportunities and putting in place collaborations with major therapeutic oligonucleotide companies with the goal to build LGC Biosearch oligonucleotide business unit from the ground up

 

• Primary contact for contract negotiations and transactions involving research and pre-clinical therapeutic oligonucleotides and oligonucleotides for DNA encoded library technology.

 

• General review of market trends, opportunities, competitors in the field of therapeutic oligonucleotides and DNA encoded library discovery

 

• Development of sales presentation and marketing collateral (brochures, specification sheets, website content and updates) to expand company into multi-million oligonucleotide market and to create new partnerships with large pharmaceutical companies (targeted the Asian market segment as well as the US and Europe and brought in several high revenue key accounts)

 

• Represented LGC Biosearch at trade shows, scientific meetings and industry networking events

 

Eurogentec North America, San Diego CA Jul 2009 – Sept 2013 Production/Project Manager

 

Accountable for building a manufacturing team from the ground up and for overseeing the manufacturing process of oligonucleotides for diagnostic use under GMP and ISO 9001 and 13485 regulations in the Life Science division of a $5 billion producer of chemical products

 

• As production manager of 6 chemists (BS and MS level) in the synthesis and purification departments of the oligonucleotide manufacturing unit at Eurogentec, managed several projects (30-50 projects/month) by allocating human and financial resources, implementing the process and the quality control against contract, reviewing batch records, final product inspection and product and data delivery

 

• Worked cross-functionally with QA on FDA and ISO 13485 quality system implementation and maintenance to deliver the highest quality products with minimal customer complaints

 

• Assessed continual improvement of the manufacturing process to produce diagnostic oligonucleotides with the highest quality against contract at very competitive price for customers and high margins for the company

 

• Represented Manufacturing in internal and external audits that resulted in increased volume of business for the company and established it as a key player in the molecular diagnostic market

 

• Conducted investigations related to quality anomalies, organized remedial action where appropriate and performed follow up on corrective and preventive actions

 

• Developed, revised and reviewed SOPs to improve and maintain the FDA and ISO 13485 certification and pass audits with fewer than 3 recommendations for improvement and no non-conformities

 

• Applied performance measurement metrics to track performance in all production areas; used these metrics as a guide for continuous improvement of manufacturing process and quality.

 

• Developed and evaluated team training and performance for continuous improvement and in accordance to the quality policy


BioFocus DPI, San Diego Mar 2007 – Apr 2009 Sr. Research Scientist/Supervisor

 

Supervisor of Research Scientists in GLP production of custom libraries of small molecules for the pharmaceutical industry

 

• Developed, produced and managed several big projects (combinatorial synthesis of small molecules) such as Amgen, Astra Zeneca and Novartis by developing synthetic process, implement quality control against contract, compiling monthly reports, final product inspection, shipment, and data delivery

 

• In charge of internal project audition and progress update of projects to upper managements, business development, financial departments and clients with formal reports and presentations

 

Chembridge Research Laboratories, San Diego, CA Jan 2002 – Apr 2006

Chemistry Research and Medicinal Chemistry Support

 

Sr. Research Scientist/Supervisor

 

• While supervising a team of scientists-research associates, designed and executed routes to safe and economically viable syntheses of scaffolds, building blocks and templates for scale-up within the chemistry group as part of collaborations with major pharmaceutical companies. Managed part of a multi-million Pfizer project where over 70 heterocyclic building blocks were manufactured on large scale for their drug discovery program

 

• Provided monthly verbal and written progress reports and presented quarterly research updates at Chemical Working Group meetings with clients

 

Chembridge Research Laboratories, San Diego, CA May 2001 – Dec 2001

High Throughput Chemistry

 

Scientist/Supervisor

 

Result oriented project manager/team leader of a team of four scientists (PhD and MS Chemists) in a start-up environment. Contributed to the company swift expansion and exponential growth with accomplishing and delivering quality results under very strict timelines

 

• Responsible for process development, human resources allocation, synthesis and quality control of 5500 unique compounds in an eight-month timeframe

 

• Project management involving database manipulation, SD file generation, Gantt charts to meet aggressive timelines, monthly oral and written presentations to customers on the progress of R&D and production

 

• Conducted training and performance evaluations of team members, including recommendations for promotion

 

Isis Pharmaceuticals Inc. Carlsbad, (CA)

Development Chemistry Department, Process Organic Chemistry Sep 1996 – May 1999

 

Scientist

 

• Participated in the launch of the first FDA approved antisense oligonucleotide, Vitravene, with the optimization of the automated synthesis cycle and scale-up to kilo quantities

 

• Process development included elimination of all chlorinated solvents from the synthesis cycle, substitution of potentially explosive tetrazole with DCI, sulfurization with a proprietary reagent (PADS) that afforded a safer and more cost effective synthetic process.

 

• Co-author of 8 peer reviewed scientific articles on the optimization of synthesis of oligonucleotide phosphorothioates and a patent on a one-pot synthesis of phosphoramidite building blocks without the use of an additional activator

 

_____________________________________________________________________________________________________________

 

EDUCATION AND TRAINING

 

School of Pharmacy, University of Camerino, Italy

 

Doctorate in Pharmaceutical Sciences (Major: Medicinal Chemistry), Honors, Graduated top of class

 

Emory University, Atlanta, GA, Post-doctoral Scientist. Medicinal Chemistry Department

 

Co-author of 4 peer reviewed articles on heterocycles as potential antiviral agents and boronated nucleosides (L and D) for boron neutron capture therapy as potential anti-tumor agents (brain and prostate cancer)

 

King’s College London, London, UK, Post-doctoral Scientist Organic Chemistry Department

 

Co-author of 2 peer reviewed scientific articles on the synthesis and characterization of modified nucleosides and thionucleosides as potential antiviral agents

 

DOT Hazardous Material Training and Certification, San Diego 2009

 

ISO 13485 Training, San Diego 2009-2013

21 CFR 820 Certification, San Diego 2010

 

21 CFR parts 210 and 211 Training, San Diego 2014


邀请函

下载邀请函

赞助企业

×
留下姓名电话和邮箱,邀请函直接发送到邮箱
*姓名:
* 电话:
* Email: